The findings suggest existing therapies for other cancers may be helpful in multiple myeloma (MM). Investigators have identified a biomarker associated with poor outcomes in multiple myeloma (MM) that ...
Higher TIL levels in ERBB2-positive breast cancer correlate with improved DDFS and OS, suggesting a prognostic role. Patients with TILs greater than or equal to 20% may safely undergo shorter ...
Higher tumor-infiltrating lymphocyte (TIL) levels were independently associated with improved overall survival in patients with early-stage ERBB2-positive breast cancer. Each 5% increase in TILs was ...
Neoadjuvant talazoparib (TALA) for operable breast cancer patients with a BRCA mutation (BRCA+). This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does not include a ...
A team of researchers at Weizmann Institute has regenerated heart cells in adult mice using a specialized protein called ERBB2. When a heart attack strikes, heart muscle cells die and scar tissue ...
Hypoalbuminemia as a Predictive Biomarker of Dyspnea Response to Dexamethasone and Placebo in Patients With Cancer: Secondary Analysis of the ABCD Randomized Clinical ...
Triple-negative breast cancer (TNBC), particularly the luminal androgen receptor (LAR) subtype, presents significant challenges due to its low proliferation rate, high metastatic potential, and ...
"This study raises important questions deserving further consideration—notably how the location of the mutation in the HER2 protein and co-occurring mutations may impact the efficacy of HER2-targeting ...
Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory. This joint project will make available the functional output of Variants of Unknown Significance throughout key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results